Seagen Appoints David Epstein As New CEO

RTTNews | 979 days ago
Seagen Appoints David Epstein As New CEO

(RTTNews) - Biotechnology company Seagen Inc. (SGEN) announced Thursday that its Board of Directors has appointed David Epstein as Chief Executive Officer (CEO) and a member of the Board of Directors.

Epstein brings more than 30 years of experience in the biopharmaceutical industry, including more than 25 years at Novartis where he built its oncology business unit from initiation to second largest in the world.

He then served as CEO of Novartis Pharmaceuticals, a division of Novartis AG, from 2010 to mid-2016. More recently, he was executive partner at Flagship Pioneering.

In addition, Seagen announced that Roger Dansey, M.D., who has served as Seagen's Chief Medical Officer (CMO) since 2018 and as Interim CEO since May 2022, has been appointed President, Research and Development.

In this new role, Dansey will continue to serve as CMO reporting to Epstein.

read more
Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Closes $43 Bln All-cash Acquisition Of Seagen

Pfizer Inc. (PFE) announced Thursday the successful completion of its acquisition of biotechnology company Seagen Inc. (SGEN). Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion.
RTTNews | 580 days ago
U.S. Industrial Production Climbs 0.3% In June, More Than Expected

U.S. Industrial Production Climbs 0.3% In June, More Than Expected

Partly reflecting a surge by utilities output, the Federal Reserve released a report on Wednesday showing industrial production in the U.S. increased by more than expected in the month of June. The Fed said industrial production climbed by 0.3 percent in June, while revised data showed industrial production was unchanged in May.
RTTNews | 2h 38min ago
Bay Street May Open With Positive Bias

Bay Street May Open With Positive Bias

Canadian shares may open with a slightly positive bias on Wednesday, although weak crude oil prices might limit the market's upside. Investors will focus on trade talks and earnings announcements from big name U.S. companies for directional clues.
RTTNews | 4h 2min ago